🔗 Share this article

An underground market for unapproved weight-loss drugs is being driven by TikTok fitness influencers and vendors on communication apps, based on recent findings.

Investigational Drug Acquiring Traction Via Social Media

Retatrutide, which is still in clinical trials, is being advertised by social media influencers for its alleged fat-burning properties. Viewers are urged to contact these accounts directly for supplier links, while also receiving discount codes.

Active Commerce on Social Networks

Additionally, a robust trade exists on Telegram, where groups with numerous of members share “before and after” photos, injection guides and assertions of rapid UK delivery. Sellers promote the substance there before redirecting buyers to other platforms for purchases.

Understanding The Experimental Drug

Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help patients reduce up to a quarter of their total weight. Referred to as the “triple G”, the drug is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Worries

However, physicians and chemists have warned that the distribution of what remains an unapproved medication in the United Kingdom is a cause for concern and could lead to users administering products of uncertain source.

Some experts said the popularity for the experimental drug could be connected to the increasing price of licensed slimming products such as Mounjaro.

Legal Status and Implementation

Selling the unapproved drug on TikTok or Telegram is illegal in the UK, as it is an unlicensed drug that must not be marketed or supplied for human use under the British medical regulations.

Some content creators attempt to circumvent the regulations by referring to the drug as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but advertising and distribution can still breach pharmaceutical, marketing, and consumer laws, potentially leading to fines, legal action or prison.

Platform Reaction and Content Removal

According to the social media company, the service has removed violative content and prohibited associated hashtags and search suggestions. The company said it was committed to keeping the platform secure and allocating resources in enhancing compliance measures.

Online Marketplace Operations

Research also discovered communities with up to nine thousand members marketing retatrutide using Telegram's built-in search feature, which functions like a public directory. Entering “retatrutide” instantly displays groups with thousands of users, filled with photos of slimming results, glowing reviews and detailed instructions for preparing or injecting at home.

After minutes of joining one community, a vendor shared WhatsApp details, where most transactions take place. The seller provided an instruction manual and guaranteed delivery within 48 hours. When questioned whether the product was genuine, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one inquired about weight, medical conditions or past usage.

Product Details and Costs

Within these communities, messages show black plastic parcels with postal service stickers, stating to contain fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Customers can choose between dry substance containers, prepared at home with sterile water, or ready-to-use pens typically sold at £160 for 20 milligrams. When asked how much time a pen should be used, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Oversight and Safety Actions

A spokesperson for the messaging service said it actively moderated dangerous content on its service including content that promoted the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they cannot confirm. Even if the science behind retatrutide is sound, these digital products may not include what they claim,” stated Jason Murphy, the head of pharmacy at a pharmacy service.

A medical professional of Asda Online Doctor connected the increase in demand to recent price rises for authorized weight-loss medications such as Mounjaro. “With prices increasing, individuals are turning to online platforms. But fake injections are highly risky. You can’t be certain what’s contained or whether the conditions they were produced in was sterile,” she said.

Her staff has previously encountered patients injured by self-injection from unverified sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” stated Wyllie. “These materials could be contaminated or improperly measured.”

Manufacturer Statement

A representative from the pharmaceutical company stated the substance was in third stage clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they said, noting that any product “misleadingly claiming itself as a Lilly investigational product not yet authorized … may subject patients to potentially significant medical dangers”.